OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Multiple strategies have been employed maximize antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion processes. Fine-tuning growth parameters